Prognostic Impact of Cancer Inflammation Prognostic Index for Non-small Cell Lung Cancer

ConclusionCIPI was a significant factor for RFS in NSCLC patients treated surgically, even in those with pathological stage I disease. SUVmax was also a significant factor for RFS and overall survival in NSCLC patients treated surgically, and for RFS in patients with pathological stage I NSCLC.Trial RegistrationThe Institutional Review Board of Kanazawa Medical University approved the protocol of this retrospective study (Approval Number: I392), and written informed consent was obtained from all patients.
Source: Lung - Category: Respiratory Medicine Source Type: research